The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain

S. Caccia, M. Anelli, A. M. Codegoni, C. Fracasso, S. Garattini

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

1. The effects of acute and repeated equiactive anorectic doses (ED50) of recently marketed 5-hydroxytryptamine (5-HT) uptake inhibitors on the content of brain indoles were compared in rats in relation to the brain regional concentrations of unchanged drug and its known active metabolite. 2. Single intraperitoneal (i.p.) doses of the anorectic ED50 of fluoxetine (35 μmol kg-1), fluvoxamine (60 μmol kg-1), paroxetine (20 μmol kg-1) and sertraline (49 μmol kg-1) slightly reduced brain 5-hydroxyindoleacetic acid (5-HIAA), with regional differences, this being compatible with 5-HT uptake blockade. Only fluvoxamine and sertraline significantly enhanced the content of 5-HT in the cortex. 3. The regional sensitivity to the acute effect of a given drug was not related to any preferential drug distribution, as these compounds distributed almost uniformly in the brain areas considered (cortex, striatum and hippocampus). 4. Repeating the same doses twice daily, i.p. for 14 days, however gave a different picture, fluvoxamine having little or no effect on the content of indoles and fluoxetine, paroxetine and sertraline lowering both 5-HY and 5-HIAA in all the brain regions compared to pair-fed control animals, 1 h after the last dose. 5. One week later only fluoxetine-treated animals still had reduced brain 5-HT, this probably being related to the accumulation of its main metabolite norfluoxetine in rat brain after chronic dosing. 6. Further studies on the relationship between the long-term neurochemical changes and anorectic activity are required but it appears from these results that anorectic drugs with similar acute effects on 5-HT uptake may differ in their long-term effects on 5-HT mechanisms.

Original languageEnglish
Pages (from-to)355-359
Number of pages5
JournalBritish Journal of Pharmacology
Volume110
Issue number1
Publication statusPublished - 1993

Fingerprint

Appetite Depressants
Serotonin Uptake Inhibitors
Serotonin
Fluvoxamine
Sertraline
Brain
Fluoxetine
Indoles
Paroxetine
Hydroxyindoleacetic Acid
Pharmaceutical Preparations
indole
Hippocampus

Keywords

  • 5-hydroxytryptamine
  • Anorectic drugs
  • Brain
  • Fluovoxamine
  • Fuoxetine
  • Indoles
  • Paroxetine
  • Sertraline

ASJC Scopus subject areas

  • Pharmacology

Cite this

The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain. / Caccia, S.; Anelli, M.; Codegoni, A. M.; Fracasso, C.; Garattini, S.

In: British Journal of Pharmacology, Vol. 110, No. 1, 1993, p. 355-359.

Research output: Contribution to journalArticle

@article{78f08c65e67840c6968877d97407a9be,
title = "The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain",
abstract = "1. The effects of acute and repeated equiactive anorectic doses (ED50) of recently marketed 5-hydroxytryptamine (5-HT) uptake inhibitors on the content of brain indoles were compared in rats in relation to the brain regional concentrations of unchanged drug and its known active metabolite. 2. Single intraperitoneal (i.p.) doses of the anorectic ED50 of fluoxetine (35 μmol kg-1), fluvoxamine (60 μmol kg-1), paroxetine (20 μmol kg-1) and sertraline (49 μmol kg-1) slightly reduced brain 5-hydroxyindoleacetic acid (5-HIAA), with regional differences, this being compatible with 5-HT uptake blockade. Only fluvoxamine and sertraline significantly enhanced the content of 5-HT in the cortex. 3. The regional sensitivity to the acute effect of a given drug was not related to any preferential drug distribution, as these compounds distributed almost uniformly in the brain areas considered (cortex, striatum and hippocampus). 4. Repeating the same doses twice daily, i.p. for 14 days, however gave a different picture, fluvoxamine having little or no effect on the content of indoles and fluoxetine, paroxetine and sertraline lowering both 5-HY and 5-HIAA in all the brain regions compared to pair-fed control animals, 1 h after the last dose. 5. One week later only fluoxetine-treated animals still had reduced brain 5-HT, this probably being related to the accumulation of its main metabolite norfluoxetine in rat brain after chronic dosing. 6. Further studies on the relationship between the long-term neurochemical changes and anorectic activity are required but it appears from these results that anorectic drugs with similar acute effects on 5-HT uptake may differ in their long-term effects on 5-HT mechanisms.",
keywords = "5-hydroxytryptamine, Anorectic drugs, Brain, Fluovoxamine, Fuoxetine, Indoles, Paroxetine, Sertraline",
author = "S. Caccia and M. Anelli and Codegoni, {A. M.} and C. Fracasso and S. Garattini",
year = "1993",
language = "English",
volume = "110",
pages = "355--359",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain

AU - Caccia, S.

AU - Anelli, M.

AU - Codegoni, A. M.

AU - Fracasso, C.

AU - Garattini, S.

PY - 1993

Y1 - 1993

N2 - 1. The effects of acute and repeated equiactive anorectic doses (ED50) of recently marketed 5-hydroxytryptamine (5-HT) uptake inhibitors on the content of brain indoles were compared in rats in relation to the brain regional concentrations of unchanged drug and its known active metabolite. 2. Single intraperitoneal (i.p.) doses of the anorectic ED50 of fluoxetine (35 μmol kg-1), fluvoxamine (60 μmol kg-1), paroxetine (20 μmol kg-1) and sertraline (49 μmol kg-1) slightly reduced brain 5-hydroxyindoleacetic acid (5-HIAA), with regional differences, this being compatible with 5-HT uptake blockade. Only fluvoxamine and sertraline significantly enhanced the content of 5-HT in the cortex. 3. The regional sensitivity to the acute effect of a given drug was not related to any preferential drug distribution, as these compounds distributed almost uniformly in the brain areas considered (cortex, striatum and hippocampus). 4. Repeating the same doses twice daily, i.p. for 14 days, however gave a different picture, fluvoxamine having little or no effect on the content of indoles and fluoxetine, paroxetine and sertraline lowering both 5-HY and 5-HIAA in all the brain regions compared to pair-fed control animals, 1 h after the last dose. 5. One week later only fluoxetine-treated animals still had reduced brain 5-HT, this probably being related to the accumulation of its main metabolite norfluoxetine in rat brain after chronic dosing. 6. Further studies on the relationship between the long-term neurochemical changes and anorectic activity are required but it appears from these results that anorectic drugs with similar acute effects on 5-HT uptake may differ in their long-term effects on 5-HT mechanisms.

AB - 1. The effects of acute and repeated equiactive anorectic doses (ED50) of recently marketed 5-hydroxytryptamine (5-HT) uptake inhibitors on the content of brain indoles were compared in rats in relation to the brain regional concentrations of unchanged drug and its known active metabolite. 2. Single intraperitoneal (i.p.) doses of the anorectic ED50 of fluoxetine (35 μmol kg-1), fluvoxamine (60 μmol kg-1), paroxetine (20 μmol kg-1) and sertraline (49 μmol kg-1) slightly reduced brain 5-hydroxyindoleacetic acid (5-HIAA), with regional differences, this being compatible with 5-HT uptake blockade. Only fluvoxamine and sertraline significantly enhanced the content of 5-HT in the cortex. 3. The regional sensitivity to the acute effect of a given drug was not related to any preferential drug distribution, as these compounds distributed almost uniformly in the brain areas considered (cortex, striatum and hippocampus). 4. Repeating the same doses twice daily, i.p. for 14 days, however gave a different picture, fluvoxamine having little or no effect on the content of indoles and fluoxetine, paroxetine and sertraline lowering both 5-HY and 5-HIAA in all the brain regions compared to pair-fed control animals, 1 h after the last dose. 5. One week later only fluoxetine-treated animals still had reduced brain 5-HT, this probably being related to the accumulation of its main metabolite norfluoxetine in rat brain after chronic dosing. 6. Further studies on the relationship between the long-term neurochemical changes and anorectic activity are required but it appears from these results that anorectic drugs with similar acute effects on 5-HT uptake may differ in their long-term effects on 5-HT mechanisms.

KW - 5-hydroxytryptamine

KW - Anorectic drugs

KW - Brain

KW - Fluovoxamine

KW - Fuoxetine

KW - Indoles

KW - Paroxetine

KW - Sertraline

UR - http://www.scopus.com/inward/record.url?scp=0027313688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027313688&partnerID=8YFLogxK

M3 - Article

C2 - 7693282

AN - SCOPUS:0027313688

VL - 110

SP - 355

EP - 359

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 1

ER -